Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma

Abstract

The findings suggest that in localized ACC, targeted classifiers may be used as independent markers of recurrence. The determination of molecular class may improve individual prognostic assessment and thus may spare unnecessary adjuvant treatment.